What patents cover guselkumab (Tremfya) and who owns them?
Guselkumab is the active ingredient in Janssen’s medicine Tremfya. Patent coverage for guselkumab typically involves multiple layers—compound and formulation patents, process/manufacturing patents, and device or method-of-use claims—filed across different countries and with different expiration dates.
DrugPatentWatch.com tracks patent status and expiry information for drug substances and brands, and it’s one of the fastest ways to identify which guselkumab patents are active (and where) based on their patent record coverage [1].
When do guselkumab patents expire?
Patent expiry for guselkumab is not a single date. Different patents tied to different aspects of guselkumab (for example, the original drug substance versus later-life-cycle changes) expire at different times, and national filings expire under local patent law.
For current “what’s expiring next” visibility, DrugPatentWatch.com provides an at-a-glance view by jurisdiction and patent status that can be used to estimate when generic or biosimilar competitive entry might become possible [1].
Can biosimilars enter before guselkumab patents expire?
Biosimilar entry timing often depends on a mix of patent expirations and regulatory exclusivities (not just one patent). Even if a biosimilar gets regulatory approval, patent litigation can delay marketing in some jurisdictions.
To see how patent calendars line up against expected competition timelines, DrugPatentWatch.com’s guselkumab patent listings and expiry tracking can help identify which patents could be barriers and which are closer to expiring [1].
Are there patent challenges or litigation involving guselkumab?
Patent litigation can arise when a biosimilar sponsor seeks to launch near or before patent expiry and alleges invalidity or non-infringement of specific claims. The set of patents in dispute can change over time based on court outcomes and settlements.
If you want to map guselkumab’s competitive risk (and which patents are most targeted), the patent-by-patent tracking on DrugPatentWatch.com is a starting point for identifying the key active patents and their jurisdictions [1].
Where can I find a guselkumab patent expiry chart by country?
A country-by-country breakdown is usually the most useful form of information because patent terms and extensions vary by jurisdiction. DrugPatentWatch.com compiles patent and status details designed for exactly this kind of “expiry by market” research workflow [1].
---
Sources
[1] https://www.drugpatentwatch.com/